<DOC>
	<DOCNO>NCT02666690</DOCNO>
	<brief_summary>RECIST criterion evaluate tumor response often inadequate evaluation anti-angiogenic drug . An evaluation model tumor perfusion contrast-enhanced ultrasonography develop Gustave Roussy . It assess tumor vascular response analysis 7 different parameter . Several study ( four IGR , involve 117 patient , multicenter study involve 400 patient ) show CEUS allow early evaluation effect anti-angiogenic drug . Two parameter particularly interest early identification patient respond ( ) treatment . Those area curve , area wash-out . To validate use parameter , essential measure describe level intra-patient variability .</brief_summary>
	<brief_title>Study Intra-patient Variability Quantitative Parameters Tumor Perfusion Evaluated With Ultrasound Contrast</brief_title>
	<detailed_description />
	<mesh_term>Neoplasm Metastasis</mesh_term>
	<mesh_term>Neoplasms</mesh_term>
	<mesh_term>Neoplasms , Second Primary</mesh_term>
	<criteria>1 . Patient treat IGR metastatic cancer antiangiogenic ( ) drug ( ) follow indication : Gastrointestinal sarcoma ( GIST ) Breast Cancers Kidney Cancers Colorectal Cancers Melanoma These antiangiogenic drug use alone combination : Bevacizumab ( Avastin ) , imatinib ( Gleevec ) , Sorafenib ( Nexavar ) , sunitinib ( Sutent ) , Everolimus ( Afinitor ) Temsirolimus ( Torisel ) , ... ( non exhaustive list ) . 2 . With least one clearly identify metastatic tumor lesion ( accessible ultrasound acquisition 3 minute without lose target ) , measure 2 cm , le 50 % volume necrotic . Metastatic lesion : Liver ( 30 patient ) Or outside liver ( 30 patient ) 3 . Physiological Age : 1880 year 4. performance status &lt; 2 5 . Patient information signature inform consent 1 . Background known hypersensitivity sulfur hexafluoride one component , 2. recent history acute coronary syndrome unstable ischemic heart disease , 3 . Acute heart failure , heart failure stage III IV , severe rhythm disorder , 4. uncontrolled hypertension severe pulmonary hypertension , 5 . RightLeft Shunt , 6 . Respiratory Distress Syndrome , 7 . Patient without vascularized tumor ( without contrast enhancement ) 8. patient whose antiangiogenic already start , 9 . Pregnant woman likely breastfeeding , 10 . Persons deprive liberty guardianship , 11 . Unable submit medical monitoring trial geographical , social psychological reason</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>June 2016</verification_date>
</DOC>